240 related articles for article (PubMed ID: 35077194)
41. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
42. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
[TBL] [Abstract][Full Text] [Related]
43. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
44. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
[TBL] [Abstract][Full Text] [Related]
45. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
46. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
47. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
48. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
49. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.
Tsai RJ; Dennis LK; Lynch CF; Snetselaar LG; Zamba GK; Scott-Conner C
Ann Surg Oncol; 2009 Jul; 16(7):1959-72. PubMed ID: 19365624
[TBL] [Abstract][Full Text] [Related]
50. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
52. Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer.
Pasko JL; Garreau J; Carl A; Ansteth M; Glissmeyer M; Johnson N
Am J Surg; 2015 May; 209(5):890-5. PubMed ID: 25796096
[TBL] [Abstract][Full Text] [Related]
53. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging.
Aldrich MB; Rasmussen JC; DeSnyder SM; Woodward WA; Chan W; Sevick-Muraca EM; Mittendorf EA; Smith BD; Stauder MC; Strom EA; Perkins GH; Hoffman KE; Mitchell MP; Barcenas CH; Isales LE; Shaitelman SF
Breast Cancer Res Treat; 2022 Aug; 195(1):33-41. PubMed ID: 35816269
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer related lymphedema in patients with different loco-regional treatments.
Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
[TBL] [Abstract][Full Text] [Related]
55. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
56. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
57. [Axillary reverse mapping--chance to prevent lymphedema in breast cancer patients].
Pavlista D; Koliba P; Eliska O
Ceska Gynekol; 2011 Oct; 76(5):355-9. PubMed ID: 22132635
[TBL] [Abstract][Full Text] [Related]
58. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
Parks RM; Cheung KL
Breast; 2017 Jun; 33():57-70. PubMed ID: 28282588
[TBL] [Abstract][Full Text] [Related]
59. Immediate Lymphatic Reconstruction to Prevent Breast Cancer-Related Lymphedema: A Systematic Review.
Cook JA; Sinha M; Lester M; Fisher CS; Sen CK; Hassanein AH
Adv Wound Care (New Rochelle); 2022 Jul; 11(7):382-391. PubMed ID: 34714158
[No Abstract] [Full Text] [Related]
60. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]